| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CONDUIT PHARMACEUTICALS INC. | Director | Stock Option (Right to Buy) | 0 | $0 | $5.51 | 13 May 2024 | Direct |
| Codex DNA, Inc. | Chief Financial Officer | Stock Option (right to buy) | 107,300 | 27 Feb 2022 | Direct | ||
| Codex DNA, Inc. | Chief Financial Officer | Restricted Stock Unit | 28,000 | 27 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CDT | CONDUIT PHARMACEUTICALS INC. | 13 May 2024 | 1 | -$358,150 | 4 | Director | 15 May 2024, 16:30 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 01 Dec 2023 | 1 | +$358,150 | 4 | Director | 05 Dec 2023, 17:20 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 22 Sep 2023 | 0 | $0 | 3 | Director | 26 Sep 2023, 17:43 |
| TBIO | Codex DNA, Inc. | 27 Feb 2022 | 2 | $0 | 4 | Chief Financial Officer | 01 Mar 2022, 15:30 |
| TBIO | Codex DNA, Inc. | 17 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 17 Jun 2021, 10:58 |